Searchable abstracts of presentations at key conferences in endocrinology

ea0086cmw1.3 | Endocrine disease in pregnancy: pitfalls in testing and challenges in management; before, during and after | SFEBES2022

Hyperthyroidism

Korevaar Tim

In this presentation I will discuss various aspects of hyperthyroidism during pregnancy. First of all, I will discuss that the epidemiology points towards a physiological underlying cause but I will also exhibit the differential diagnoses that should be addressed. Second, I will discuss preconception and gestational management of Graves’ disease, specifically focusing on new concepts regarding antithyroid drug choice, cessation and options in case of antithyroid drug fai...

ea0049s5.1 | Turn your face to the sunshine | ECE2017

Effects of maternal thyroid function on infant neurodevelopment

Korevaar Tim

In this talk I aim to provide a helicopter view of clinical studies on maternal thyroid function and child neurodevelopment and use this to pinpoint out how different viewpoints on the results can help to interpret the clinical relevance of the currently available data and provide handles to make personal but informed clinical decisions. It is well-established that thyroid hormone plays an important role during early stages of fetal brain development. Thyroid hormone-dependent...

ea0070pl6 | It takes thyroid hormone to make sense | ECE2020

Maternal thyroid hormone and child brain development

Korevaar Tim

During this presentation, I will share my views on the effects of maternal thyroid hormone on child brain development. I will discuss the physiology of maternal thyroid function during pregnancy and how this relates to time-dependent processes of fetal brain development. I will also discuss the various aspects of assessing fetal brain development. This is particularly important because we can only assessments fetal brain development in the children after birth, and we have to ...

ea0044oc6.2 | Pregnancy and Reproductive Health | SFEBES2016

The thyroidal response to hCG stimulation is impaired in women with subclinical hypothyroidism and is influenced by BMI, fetal sex and parity

Korevaar Tim , Chaker Layal , Visser Theo , Peeters Robin

Introduction: Although hCG is an important determinant of gestational thyroid function, it is unknown to what extent hCG is a risk factor for thyroid disease and we also lack knowledge on which characteristics influence the thyroidal response to hCG stimulation.Methods: hCG, TSH, FT4 and TPOAbs were measured in 5435 pregnant women (<18 weeks) in a prospective cohort. Subclinical disease entities were defined according to P2.5-P97.5 in TPOAb negative ...

ea0041oc4.1 | Thyroid - Clinical | ECE2016

Additional measurement of hCG distinguishes physiological high-normal thyroid function and reveals large differences in the risk of developing preeclampsia

Korevaar Tim , Steegers Eric , Medici Marco , Visser Theo , Peeters Robin

Context: Preeclampsia is a leading cause of maternal and perinatal morbidity and mortality worldwide, affecting 2–8% of all pregnancies. We have previously shown that women with high-normal levels of FT4 during early pregnancy have a 2.1-fold increased risk of preeclampsia – but there was no apparent association with low TSH. However, the thyroid is stimulated by human chorionic gonadotropin (hCG) during early pregnancy and therefore we hypothesized that women with h...

ea0028p43 | Clinical practice/governance and case reports | SFEBES2012

Disconnection hyperprolactinaemia in non-adenomatous sellar/parasellar lesions practically never exceeds 2000 mU/L

Korevaar Tim , Wass John , Grossman Ashley , Karavitaki Niki

Hyperprolactinaemia in association with a large sellar lesion could represent either tumoural secretion of prolactin (PRL) or stalk disruption by a non-prolactinoma: the differentiation has important therapeutic consequences. We have previously shown that based on currently used assays disconnection hyperprolactinaemia associated with non-functioning adenoma (NFA) practically never exceeds levels above 2000 mU/l. We aimed to verify our proposed disconnection hyperprolactinaemi...

ea0081oc11.4 | Oral Communications 11: Thyroid 2 | ECE2022

Association of thyroid function and TPO positivity with the risk of postpartum depression: a population-based cohort study and systematic review

Sileo Federica , Osinga Joris , Visser Edward , Derakhshan Arash , citterio valeria , Persani Luca , Korevaar Tim

Background: Postpartum depression (PPD) is a common mental health disorder with a major impact on maternal health and wellbeing and offspring development. Thyroperoxidase antibody (TPOAb) positivity is a major risk factor for postpartum thyroiditis and via this link, it is hypothesized that TPOAb positivity is a risk factor for PPD. However, the results of currently available single center studies are heterogeneous and affected by major study limitations.<p class="abstext"...

ea0081yi3 | Young Investigator Awards | ECE2022

Generalization of TSH and FT4 reference intervals in pregnancy: an individual participant data meta-analysis

Osinga Joris , Derakhshan Arash , Consortium on thyroid and pregnancy working group on reference intervals , Peeters Robin , Korevaar Tim

Objective: Defining thyroid function test abnormalities in pregnancy is complicated by changes in maternal physiology. Ideally, reference intervals (RIs) should be population-based and pregnancy-specific. Large methodological differences between published reports limit the adoption of such RIs into clinical practice.Methods: The study was performed in the Consortium on Thyroid and Pregnancy. In line with current consensus and the 2017 American Thyroid As...

ea0081p716 | Thyroid | ECE2022

Antenatal thyroid hormone therapy and antithyroid drug use in Norway from 2004 to 2018

Bakken Kjersti , Nermo Kristina , Gunnar Nedrebo Bjorn , IM Korevaar Tim , Strand Tor A.

Thyroid disease during pregnancy is associated with adverse pregnancy outcomes and suboptimal fetal development. During the last decades, guidelines for diagnosing thyroid disease during pregnancy have changed considerably, and there has been increased awareness. This study aimed to describe the prevalence of thyroid disease treatment over time among pregnant women in Norway. We combined historical data from the Medical Birth Registry of Norway and the Norwegian Prescription D...

ea0084op-02-11 | Oral Session 2: Pregnancy | ETA2022

Association of thyroid function and tpoab positivity with the risk of postpartum depression: A population-based cohort study, systematic review, and meta-analysis

Sileo Federica , Osinga Joris , Edward Visser W. , Derakhshan Arash , Citterio Valeria , Persani Luca , Korevaar Tim

Background: Postpartum depression (PPD) is a common mental health disorder with a major impact on maternal health and wellbeing and offspring development. Thyroperoxidase antibody (TPOAb) positivity is a major risk factor for postpartum thyroiditis and via this link, it is hypothesized that TPOAb positivity is a risk factor for PPD. However, the results of currently available single center studies are heterogeneous and affected by major study limitations.<p class="abstext"...